.ANALYSIS FEATURE.06 August 2024.
A big randomized measured test with cisgender females highlights the problems of faithfulness to a regular dental preexposure prevention regiment as well as shows that twice-yearly treatment of lenacapavir can preserve helpful HIV protection levels over 6 months.